Integrated Diagnostics, a US-based medical diagnosis company with close links to Luxembourg, has gained $10m in its $30m series A round and seen a change of investors in its consortium.
BioTechCube (BTC), a newly-formed Luxembourg-based investment company backed by the state, replaced dievini Hopp BioTech, the life sciences investment firm of Germany-based software company SAP co-founder Dietmar Hopp, in the venture consortium.
The other investors remain venture capital firm InterWest Partners and UK-based medical endowment Wellcome Trust.
Patrizia Luchetta, chair of BTC and head of the Life Sciences and Technologies Department at the Ministry of the Economy and Foreign Trade in Luxembourg, will join the company’s board.
Integrated Diagnostics uses genomic and proteomic techniques to identify and detect organ-specific blood proteins that appear at the earliest stage of disease. This work is based on research at The Institute for Systems Biology (ISB), which established ongoing research collaborations with the University of Luxembourg in 2008. In 2009 Integrated Diagnostics became the first commercial enterprise to arise from this partnership between Luxembourg and three US universities.